Intelligence for the Dealmaking Community since 1965
Intelligence for the Dealmaking Community since 1965
After clicking on a story, use the back arrow in your browser to return to your search results. Use phrases "in quotes" or the tools below to better filter your results.
This is premium content

To read the full story, please upgrade your plan.

Upgrade plan
Login to your account

Generic drugs

image
Healthcare
Valeant trims drug portfolio by selling iNova to Carlyle and Pacific Equity
Bourne Partners, Midatech and Cathaway Capital also made deals for pharmaceutical companies.
June 8, 2017

Trending

1.
Middle-Market M&A Finally Finds Its Footing
July 9, 2026
2.
Secondaries Edge: CVs Come of Age—and Under Scrutiny
July 8, 2026
3.
PE-Backed Pye-Barker Fire & Safety Purchases ResponseTECH
July 9, 2026
4.
Secondaries Edge: Smaller Sponsors, Sovereign Sellers and Tougher Standards
July 22, 2026
5.
War Tech Ignites M&A
July 13, 2026
6.
Inside the Lower Middle Market’s Two-Track Deal Sourcing Strategy
July 20, 2026
7.
PE’s Next Bet: Buy Companies That Need Work
July 15, 2026
8.
Morgan Stanley Expects Record $6.4T Global M&A Market in 2026
July 9, 2026
9.
Why LPs Are Still Committing to Some LMM Funds
July 14, 2026